Fibrocystic Breast Condition (cont.)
Melissa Conrad Stöppler, MD
Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.
William C. Shiel Jr., MD, FACP, FACR
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
In this Article
- What are fibrocystic breasts?
- Is there a difference between fibrocystic breast condition and fibrocystic breast disease?
- What causes fibrocystic breasts?
- Which women are more likely to develop fibrocystic breast condition?
- Can fibrocystic breast condition affect just one breast?
- Why is it important to diagnosis fibrocystic breasts?
- How is fibrocystic breast condition diagnosed?
- Is there more than one type of fibrocystic breast condition?
- Why can fibrocystic breast condition be associated with an increased risk of breast cancer?
- Why don't all women with fibrocystic breast condition have breast biopsies?
- What is the recommended follow-up for women with fibrocystic breast condition?
- How is the risk of breast cancer in fibrocystic breast condition patients calculated?
- What are the treatments for fibrocystic breast condition?
- Are there any dietary or life style factors associated with fibrocystic breast condition?
- Fibrocystic Breast condition At A Glance
- Find a local Obstetrician-Gynecologist in your town
Which women are more likely to develop fibrocystic breast condition?
Fibrocystic breast condition is said to primarily affect women age 30 and older. The reason for this is that the condition likely results from a cumulative process of repeated monthly hormonal cycles and the accumulation of fluid, cells, and cellular debris within the breast. The process starts with puberty and continues through menopause. After menopause, fibrocystic breast condition becomes less of a problem.
Can fibrocystic breast condition affect just one breast?
Not usually. As a rule, fibrocystic breast condition tends to be symmetrical (bilateral) and affects both breasts. A woman can have more fibrocystic involvement in one breast than in the other. The less affected breast, however, often "catches up" over the years, and eventually both breasts become almost equally fibrocystic.
Why is it important to diagnosis fibrocystic breasts?
The basic problem with fibrocystic breast condition is the threat of breast cancer. Fibrocystic breast condition is itself benign (non-cancerous) and exceedingly common. Additionally, breast cancer is a common malignancy in women. Both conditions, one benign and the other a leading cause of cancer deaths in women, involve the same organ - the breast, and both can involve the presence of breast masses.
Fibrocystic lumps in the breast can closely mimic those found in breast cancer. They can also sometimes make breast cancer difficult to detect. Therefore, fibrocystic breast condition often makes both the patient and her physician quite concerned about the possibility of breast cancer. If a woman's breasts are fibrocystic, diagnostic tests in addition to screening mammography may be necessary in order to rule out an underlying breast cancer.
Patient Comments
Viewers share their comments
- •
- Submit »
- •
- Submit »
http://www.medicinenet.com/fibrocystic_breast_condition/article.htm
Women's Health
Find out what women really need.
Updated & New
